GE Healthcare

Discovery VCT

imagination at work
Our vision.
It began with a vision. A vision to help shape a new
age of healthcare, in which disease will be better
understood so it can be detected and diagnosed
early with confidence. A vision allowing effective
treatment with therapies tailored to individual
patients. For us, that vision is Discovery™.
At GE Healthcare our goal is to accelerate
and simplify the way disease is diagnosed and
treatment is monitored. By integrating our elite
PET imaging technology with our breakthrough
volume CT, we can now provide a single system
that captures all clinically relevant information for
oncology, cardiology and neurology applications.
It’s a new approach in disease management -
but don’t take our word for it.
See. For yourself.
Discovery VCT
Leading technology, complete care. See. The complete picture.

With the best balance in resolution and sensitivity, Exclusive, clinically relevant technology To understand PET/VCT better, think about a geographic
Discovery VCT offers a complete set of clinical landscape captured from an aerial view. The different quality
Oncology
and density of vegetation is representative of a PET image,
applications to help physicians provide accurate • 4Dx – Assess cardiac and respiratory motion while the water systems are analogous to a VCT image.
disease diagnosis, staging, treatment planning for accurate lesion detection
and follow up. Our most advanced offering in PET/CT Only by combining this information together can there be a
• VUE Point – Excellent image quality with higher
true correlation between the flow of the water systems and the
technology, Discovery VCT takes you in a new path signal-to-noise ratio (SNR)
relative quality of vegetation. This information would be critical
of disease management: a single, less invasive • Rad Rx – Apply CT radiology prescription parameters to a geologist trying to restore proper irrigation to an area of
diagnostic tool for an efficient evaluation of disease. when acquiring CTAC desolate terrain. The same analogy works for PET/VCT imaging
And now with the world’s first integrated PET/CT Cardiology with a physician assessing the appropriate treatment path for
their patients.
operator’s console – Discovery Dimension – • 5-Beat Cardiac™ – Scan the entire heart in one
Discovery VCT provides physicians with a complete brief breath hold with a low dose
set of assessment tools, enabling them to see not • 2D – High count rate, low scatter fraction
only the location, but also the extent of disease, dynamic acquisition
leading to an individualized treatment path Neurology
for the patient. • Cortex ID – Easy, robust and clinically validated
review/analysis of PET and PET/CT neurological scans

PET VCT PET/VCT

See. Volume CT. 5-Beat Cardiac
Fully robust and repeatable procedure
Triple RuleOut
All in one chest pain management
Discovery VCT offers the unique opportunity to scan in just 5 The Triple RuleOut™ acquisition, based on an ECG gated
Discovery VCT incorporates GE’s 64-slice beats, imaging the coronary arteries, cavities and myocardium protocol, allows extended anatomical coverage for a patient
assessment in pure arterial phase. 5-Beat Cardiac minimizes exhibiting acute chest pain in an emergency environment.
LightSpeed™ VCT technology to give you
heart rate variability, delivering a diagnostic study for virtually This information is critical to ruling out coronary disease,
an outstanding combination of high-speed, every patient. Delivering a true coverage of 40 mm per pulmonary embolism or aortic dissection– the three most life-
sub-millimeter resolution and wide coverage rotation, a rotation speed of 0.35 sec, for an acquisition threatening causes of chest pain. All in just 12 seconds during
that is critical to diagnostic confidence. in a short breath-hold, Discovery VCT makes cardiac CT one simple, less invasive exam from a single contrast injection.
a routine examination.
With Discovery VCT, you can freeze cardiovascular
motion, view pure arterial phase imaging and Beginning of
Heart rate increase
experience excellent multi-planar reformats through breath-hold
due to hypoxia

routine high resolution acquisitions. Our industry- Heart

leading CT gives you the speed, power and image Rate
quality critical for coronary imaging. This means 5-10 seconds*
reduced imaging time, shorter breath holds, lower
exposure, wide coverage in a single acquisition and
the ability to image a broader range of patients.
*5-Beat Cardiac - acquiring a study in 5 heart beats Time
Average breath-hold on 16 channel scanner= 20 sec
Average breath-hold on VCT= 5 sec

CT Angiography Organ Perfusion

Pure arterial phase from head to toe Wide tumor coverage in one rotation
With virtually no trade-off between speed and high resolution, Volume CT perfusion provides results in the evaluation of
Discovery VCT provides a complete assessment of vascular primary tumor targets, metastases and therapy follow-up.
segments including lumen views and the vessel wall. The 4 cm coverage of Discovery VCT doubles the viewable
Optimized injection protocols combined with flexibility in the tumor size and tissue region. CT is also a technique of choice
acquisition parameters lead to a large anatomical coverage for lung nodule assessment, including growth over time and
within arterial phase and consequently to new limits in vessel progress of therapy. In addition, CT shows a growing impact
visualization. The combination of excellent image quality and on colon cancer and polyp characterization as a less invasive
color-coded plaque capability, makes CT angiography a new technique well-tolerated by the patient.
standard in vascular investigation.
See. Elite clinical PET 2D 3D 4D

performance.
In today’s PET/CT scanners, the PET event detection
and processing chain is a sophisticated balance
of many technologies including material science,
detector design/assembly and electronics.
Discovery VCT is based on our premium, reliable Imaging large patients with 2D Low dose pediatric imaging Imaging tumor motion with 4D
and upgradeable platform with the most complete with 3D
clinical acquisition choices relevant to disease
diagnosis, treatment planning and follow-up.

Highest sensitivity
The foundation of PET imaging
Discovery VCT has been optimized for advanced clinical
applications with improved spatial resolution while
maintaining high sensitivity– the foundation of PET imaging.
Our BGO crystals deliver the best sensitivity available on the
market and the highest peak NECR (Noise Equivalent Count
Rate) in the clinical range. Resolution is also improved by
the smaller matrix crystal, improved PMT and better
calibration stability.

Clinical choice
2D, 3D and 4D acquisition options
Discovery VCT provides physicians with clinically relevant
choices to image a broad patient population with a variety of
clinical conditions. Physicians can choose the optimal protocol
to see the full extent of disease while avoiding motion artifacts,
enhancing visualization and increasing quantitative accuracy.
Only GE offers 2D, 3D and 4D imaging, as well as dynamic
gated PET to help you assess the full extent of functional
parameters key to patient outcomes and prognoses.
• 2D – Cardiac applications and large patients
• 3D – Oncology applications and pediatric patients
• 4D – Motion management
See. Discovery Dimension. See. All in one.
Rad Rx – Capturing the full capability of CT with PET can be a
workflow limitation. Rad Rx offers the ability to acquire a CT scan
CT slice thickness
3.75mm

1.25mm

using the same parameters or technique used in a radiology 3.75mm

Discovery VCT includes our Discovery Dimension, prescription. The same CT scan can be used for attenuation
the first fully integrated PET/CT operator’s console correction with no need to acquire separate scans.
for improved workflow, database management

PET Scan Range

CT Scan Range
• Workflow optimization with simultaneous acquisition of Acquire the CT attenuation correction
and image review. Now clinicians can process and attenuation correction CT and radiology prescription CT and diagnostic CT in one scan with
review acquired data directly on the console, as well • Multiple series, multiple groups acquisition capability;
the ability to vary the CT parameters
to match a diagnostic CT protocol.
as manage, network and retrieve from a single any combination of helical, cine, axial
patient database. • Eliminate “banana” artifact by using cine CT acquistion
for CTAC

Whole Body FDG Scan See. Flexibility.

Scout Diagnostic & Attenuation Correction CT Scan 3D FDG Whole Body Scan
Contrast or non-contrast enhanced CT | Respiratory-gated or non-gated CT Simultaneous dynamic (gated) and static acquisition VUE Point Reconstruction – Optimal image quality in
multiple acquisition modes has always been a priority.
Rad Rx VUE Point | 4Dx VUE Point intelligent reconstruction technology, a GE
exclusive, provides a higher signal-to-noise ratio (SNR)
Myocardial Imaging and the flexibility of outstanding image quality for all
patient types in both 2D and 3D modes.
CTAC Rest Scan Pharmacological Stress Scan CTA
Calcium Score Inject and scan - generate static, gated and dynamic data Stress Inject and scan - generate static, gated and dynamic data
• Exceptional image quality in any mode
See the distinct separation of the two lesions located
4Dx | ACQC | VUE Point 4Dx | ACQC | VUE Point 5-Beat Cardiac • Images available in real-time while you scan
in the neck region in both 2D and 3D imaging modes.
• Improved quanitative accuracy

See. Motion.
4Dx – No longer will you need to bring your patients back
for a gated study. 4Dx puts motion to work for you, enabling
gated and static acquisition in the same scan for enhanced
visualization and management in areas of interest subject

Gated Scan Range

to motion.

Static Scan Range

• Simultaneous dynamic (gated) and static acquisition
• Multiple dynamic axial fields of view in the same study Complete a gated and static study
• View full extent of tumor motion for advanced radiation in a single acquisition.
treatment planning

See. True cardiac alignment.

ACQC – Now you have the ability to eliminate cardiac PET/CT
misregistration. Attenuation Correction Quality Control (ACQC)
ensures true cardiac PET and CTAC image fusion alignment.
This tool can help determine the shift vector required to
correct misalignment between the PET and CTAC data.
• Properly align PET and CT image data sets together
• Save the shift information to use in
retrospective reconstruction With ACQC, the operator is able to
• Flexibility to use any CT data set from the series properly align the PET and CT image
data sets together.
See. Vast applications.

AW VolumeShare™ image visualization and analysis Key features CardIQ Physio CardIQ Fusion VesselIQ Xpress CardIQ Function
builds on the foundation of the trusted Advantage • On-demand access to comprehensive, customizable,
Workstation® (AW) from GE Healthcare. Its advanced multi-modality analysis tools and applications
capabilities address your important clinical and • Ease-of-use to process a heavy workload, whether
workflow challenges across the enterprise — oncology, cardiology or neurology
and beyond. • One-touch segmentation, multiphase data comparison
and standard uptake values

Discovery VCT applications

• Cardiology – CardIQ Physio, CardIQ Fusion, Dynanic VUE, CardIQ™ Physio enables cardiac PET perfusion and viability reformat VesselIQ™ Xpress is a premium 2D and 3D clinical analysis tool
with quantitative analysis capability. This tool provides a GE platform for vascular studies providing fast analysis for routine cases and
SmartScore, CardIQ Xpress, VesselIQ Xpress, CardIQ Function for future, integrated PET/CT cardiac applications. easy tools for challenging ones including: plaque analysis, stenosis
and CardEP CardIQ™ Fusion is an integrated post processing image analysis quantification, aneurysm measurement and bone segmentation
• Oncology – PET/CT Fusion, Lung Volume Computer Assisted tool to effectively display, reformat and analyze 2D or 3D cardiac CT CardIQ™ Function provides quantification of the heart’s pumping
images for qualitative or quantitative assessment of heart anatomy capacity assessed by CT, to determine the need for device
Reading (VCAR), Advantage4D and AdvantageSim MD and coronary artery vessels from individual phases. implantations. This application displays cardiac CT images and
• Neurology – Perfusion 4 and Cortex ID semi-automatically or manually calculates left ventricular (LV)
and right ventricular (RV) functional parameters.

Lung VCAR AdvantageSim MD Perfusion 4 Cortex ID

Lung VCAR™ is the first application package designed specifically Perfusion 4 enables stroke management, thanks to quantitative
for volume CT imaging offering auto-visualization and quantitative maps of blood volume, blood flow, mean transit time and tumor
analysis for lung nodule diagnostics. From early detection through assessment with capillary permeability surface product. When
nodule follow-up, Lung VCAR helps clinicians provide precise and combined with VolumeShuttle, Perfusion 4 analysis can be extended
informed diagnostic decisions for improved patient management. to a large axial coverage with a single contrast injection.
AdvantageSim™ MD is the latest generation of GE Healthcare’s Cortex ID offers easy, robust and clinically validated review/analysis
industry-leading simulation and localization software for radiation of PET and PET/CT neurological scans. It allows a comparison of
therapy planning. Experience complete 4D multi-modality contouring images from age stratified normals and patient groups, depicting
in one pass – making radiotherapy planning fast and precise. brain functions that may have been altered by the disease processes.
See. Oncology.

Case A Case B
Patient History Impression Patient History
Male This patient has a history of colorectal cancer and was referred Female
71 in, 169 lbs to a PET/CT center for a follow-up to evaluate recurrence. The 72 in, 243 lbs
patient’s CEA level had been rising and complained of some
Indication abdominal discomfort. A large amount of uptake was noted in
Indication
Determine extent of disease Determine extent of disease
the left supraclavicular region and small pulmonary nodes in
Protocol the mediastinum. Multiple areas of FDG were observed in the Protocol
Injection of 12.6 mCi 18F-FDG followed by3D whole body PET liver confirming recurrent disease. Injection of 9.6 mCi 18F-FDG followed by 2D whole body PET
imaging 63 minutes later. Total scan time was 6 minutes with 1 imaging 61 minutes later. Total scan time was 12 minutes.
minute per bed position. Non-contrast enhanced, non-breath Non-contrast enhanced, non-breath hold CT images were
hold CT images were obtained over the same region for obtained over the same region for attenuation correction
attenuation correction and for correlation with PET images. and for correlation with PET images.

Impression
A large FDG avid mass was observed in the left upper lobe of
the lung. Multiple areas of FDG uptake were also noted in the
pulmonary nodules of the mediastinum.
See. Cardiology.

Case C Case D
Patient History CT Protocol Patient History CT Protocol
58 year-old male Breath-hold cardiac CT was performed using the Discovery VCT 63 year-old male Breath-hold cardiac CT was performed using the Discovery VCT
scanner with 0.35 sec rotation time. Contrast injection was 67 in, 210 lbs scanner with 0.35 sec rotation time. Contrast injection was
Indication timed and the patient received 60 cc at a rate of 5 cc/sec. timed and the patient received 60 cc at a rate of 5 cc/sec.
Evaluation for non-anginal chest pain, dyspnea and Average heart rate was 65 bpm.
Indication Average heart rate was 62 bpm.
palpitations. Cardiac risk factors include hypertension Evaluation for coronary artery disease, typical chest pain and
and diabetes with family history of ischemic heart Impression increasing fatigue with exertion. Impression
disease and obesity. The PET perfusion scan demonstrated no evidence of ischemia PET perfusion scan demonstrated a small defect in the
or scar tissue. The gated PET scan demonstrated normal global
PET Protocol anterolateral wall that is reversible. CTA showed a mild
PET Protocol left ventricular function. There is no evidence of coronary artery
Myocardial perfusion PET study following IV administration
complex plaque with non-obstructive stenosis in the LCX.
Myocardial perfusion PET study following IV administration of 61 mCi of Rubidium-82 at rest and 60 mCi of Rubidium-82
calcification. The PET/CT test results are normal, suggesting no The first obtuse marginal branch shows a stent. The left main
of 60 mCi of Rubidium-82 at rest and 60 mCi of Rubidium-82 during peak Adenosine stress, respectively. Gated images were
evidence of flow-limiting coronary artery disease. length shows severe calcification with a <50% luminal stenosis.
during peak Dypiridamole stress, respectively. Gated images obtained at rest and during peak stress.
The first diagonal branch shows a large vessel with a <50%
were obtained at rest and during peak stress. ostial stenosis. The first RPL of the RCA demonstrated a stent
that is patent. Follow-up was recommended.
Discover.
Leading technology, complete care.
© 2007 General Electric Company, doing business
as GE Healthcare.
General Electric Company reserves the right to make
changes in specifications and features shown herein,
or discontinue the product described at any time without
notice or obligation. Contact your GE representative for
the most current information.
GE, GE Monogram, Heart Fusion, CardIQ, CardEP,
Advanced Vessel Analysis, Advanced Lung Analysis,
PET/CT Fusion, Advantage Scan, Advantage4D and
Discovery are registered trademarks of GE Healthcare.

Healthcare Re-imagined

GE is dedicated to helping you transform healthcare

delivery by driving critical breakthroughs in biology
and technology. Our expertise in medical imaging
and information technologies, medical diagnostics,
patient monitoring systems, drug discovery, and
biopharmaceutical manufacturing technologies is
enabling healthcare professionals around the world
discover new ways to predict, diagnose and treat
disease earlier. We call this model of care “Early
Health.” The goal: to help clinicians detect disease
earlier, access more information and intervene
earlier with more targeted treatments, so they
can help their patients live their lives to the fullest.
Re-think, Re-discover, Re-invent, Re-imagine.
GE Healthcare
3000 North Grandview Blvd
Waukesha, WI 53188
U.S.A.
www.gehealthcare.com

imagination at work
PET-0175-04.07-EN-US